These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. Barkhouse DA, Garcia SA, Bongiorno EK, Lebrun A, Faber M, Hooper DC. J Virol; 2015 Jan 25; 89(1):312-22. PubMed ID: 25320312 [Abstract] [Full Text] [Related]
7. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Luo J, Zhang B, Wu Y, Tian Q, Zhao J, Lyu Z, Zhang Q, Mei M, Luo Y, Guo X. Vaccine; 2017 Feb 07; 35(6):938-944. PubMed ID: 28089546 [Abstract] [Full Text] [Related]
8. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B. J Virol; 2002 Apr 07; 76(7):3374-81. PubMed ID: 11884563 [Abstract] [Full Text] [Related]
11. Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs. Freuling CM, Eggerbauer E, Finke S, Kaiser C, Kaiser C, Kretzschmar A, Nolden T, Ortmann S, Schröder C, Teifke JP, Schuster P, Vos A, Mettenleiter TC, Müller T. Vaccine; 2019 Aug 02; 37(33):4750-4757. PubMed ID: 29042202 [Abstract] [Full Text] [Related]
12. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice. Liu C, Li J, Yao Q, Gao Z, Cheng Y, Zhou M, Tang Y, Sun L, Dai J, Cao G, Zhang XL, Zhang R. Vet Microbiol; 2020 Mar 02; 242():108578. PubMed ID: 32122589 [Abstract] [Full Text] [Related]
14. New approaches to the development of live attenuated rabies vaccines. Dietzschold B, Schnell MJ. Hybrid Hybridomics; 2002 Apr 02; 21(2):129-34. PubMed ID: 12031103 [Abstract] [Full Text] [Related]
15. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens. da Fontoura Budaszewski R, Hudacek A, Sawatsky B, Krämer B, Yin X, Schnell MJ, von Messling V. J Virol; 2017 Apr 15; 91(8):. PubMed ID: 28148801 [Abstract] [Full Text] [Related]
16. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo. Norton JE, Lytle AG, Shen S, Tzvetkov EP, Dorfmeier CL, McGettigan JP. PLoS One; 2014 Apr 15; 9(1):e87098. PubMed ID: 24489846 [Abstract] [Full Text] [Related]
17. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H. Vaccine; 2002 Aug 19; 20(25-26):3155-64. PubMed ID: 12163267 [Abstract] [Full Text] [Related]
18. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai L, Wang X, Wen Z, Ge J, Wang J, Zhao D, Bu Z. Antiviral Res; 2017 Oct 19; 146():36-44. PubMed ID: 28822816 [Abstract] [Full Text] [Related]